Clinical Trials Symposium

HomeProgram ▶ Clinical Trials Symposium

As part of the ATS 2022, the International Conference Committee will organize a high-profile Clinical Trials Symposium to feature new breakthroughs in treatment and management of adult and pediatric pulmonary, critical care, and sleep disorders. This session is a platform for important Phase III trial results but can also feature results from large Phase II trials that are novel and represent important new understanding.

The Clinical Trials Symposium will be programmed as a 90-minute event on Monday, May 16, 2022 from 9:30 – 11 a.m. We anticipate including 3 to 4 presentations.

Final selection of the trials for the session will be based on pre-evaluation of the key results by an International Conference Committee (ICC) sub-committee that includes the ICC Chair, ICC Chair-Appointee, and additional ICC members with clinical trials expertise as needed. All members of the ICC sub-committee will be bound by a non-disclosure agreement between ATS and the submitting organization.



Notice of Intent (NOI) Applications Open Nov. 15, 2021
NOI Application Deadline Jan. 12, 2022
ATS 2022 Late Breaker Abstract Deadline Jan. 26, 2022
ATS ICC Review Period Ends Feb. 4, 2022
Notification from ATS Feb. 11, 2022
Presenter name due to ATS Feb. 18, 2022

Important Notes:

  • Submission of an application does not guarantee a slot on the Clinical Trials Symposium or the ATS 2022 International Conference.
  • Descriptions and data submitted through the NOI process will not be published as an abstract in the conference program or the American Journal of Respiratory and Critical Care Medicine.
  • To be considered for programming independent of the Clinical Trials Symposium, submission of an abstract providing current data on the study is strongly encouraged but not required to be considered for the Clinical Trials Symposium. The Late-Breaker abstract deadline for ATS 2022 is January 26, 2022.
  • The recording of the full Clinical Trials Symposium will be available on-demand on the ATS 2022 Virtual platform after the session presentation. Full agreement to the ATS 2022 Speakers Agreement is required for participation. The recordings may also be available for sale through the ATS Store at the close of ATS 2022.  

Any questions or concerns, please email Michelle Turenne at